News

Lam Research Corp. stock underperforms Wednesday when compared to competitors despite daily gains
Shares of Lam Research Corp. LRCX advanced 1.09% to $71.67 Wednesday, on what proved to be an all-around great trading ...
Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks
NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...
Zacks Investment Research on MSN2d
Is Lam Research Stock a Buy Post Upbeat Q3 Earnings Performance?
Lam Research Corporation LRCX recently posted strong third-quarter fiscal 2025 results, helping its shares rise 7% since the ...
Rare diseases often go undiagnosed or untreated in parts of Africa. A project seeks to change that
She visited Fann hospital in Dakar, where neurologist Dr. Pedro Rodriguez measured her lung capacity. He suspects Mariama had ...
News-Medical.Net5d
Exploring ondansetron as potential therapy for opioid-exposed infants
As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen ...
Lam Research price target lowered to $90 from $100 at Raymond James
Raymond James lowered the firm’s price target on Lam Research (LRCX) to $90 from $100 and keeps an Outperform rating on the shares. Lam ...
Lam Research price target lowered to $70 from $78 at Deutsche Bank
Deutsche Bank analyst Melissa Weathers lowered the firm’s price target on Lam Research (LRCX) to $70 from $78 and keeps a Hold rating on the ...
Lam Research beats quarterly revenue estimates on surging AI chip demand
Lam Research exceeded Wall Street's third-quarter revenue expectations, driven by strong demand for advanced AI chips. This ...